The Limited Times

Now you can see non-English news...

Breakdown at Johnson & Johnson: Millions of Corona vaccine doses are involved - "Quality requirements not met"

2021-04-20T12:13:07.937Z


There are difficulties in manufacturing Johnson & Johnson's corona vaccine. American authorities and the EMA are investigating the matter. All news in the ticker.


There are difficulties in manufacturing Johnson & Johnson's corona vaccine.

American authorities and the EMA are investigating the matter.

All news in the ticker.

  • Coronavirus pandemic

    : Johnson & Johnson's corona vaccine production breaks down in the United States.

  • The US FDA and the European Medicines Agency (EMA) in Amsterdam are testing the vaccine.

  • This

    news ticker about vaccinations with Johnson & Johnson

    is updated regularly.

Munich / Amsterdam / Baltimore - The global vaccination campaign against Corona and the insidious lung disease Covid-19 has suffered further setbacks despite some significant progress.

Specifically: After a breakdown in the manufacture of the corona vaccine from Johnson & Johnson, the US drug authority FDA has called for a production stop at the affected plant in the USA.

According to the US Securities and Exchange Commission, the breakdown occurred in Baltimore in the US state of Maryland, where the company Emergent BioSolutions is involved in production.

Corona vaccine from Johnson & Johnson: Breakdown in production in the USA

The FDA is now investigating the incident, production has been stopped until further notice.

At the end of March, the US pharmaceutical company Johnson & Johnson had declared that a batch of its vaccine in the production facility in Baltimore "did not meet the quality requirements".

According to the "New York Times" it was about 15 million vaccine doses.

According to the AFP news agency, Johnson & Johnson originally wanted to deliver a further 24 million doses of vaccine against the coronavirus in April.

The vaccine has also been approved in the European Union (EU) since mid-March - and there it is a real bearer of hope.

Only on April 12, the pharmaceutical company from the United States began its deliveries to Europe.

Johnson & Johnson corona vaccine: EMA presents an opinion

Among other things, ten million doses of the vaccine should be imported into Germany during the Corona crisis by the end of June. According to the “Ärzte Zeitung”, this was at least the original plan. The advantage of the vaccine: it only needs to be administered once per person to be fully effective. Is the campaign now stalling again? The European Medicines Agency (EMA) from Amsterdam wants to give an opinion on this Tuesday.

(pm)

Source: merkur

All news articles on 2021-04-20

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.